NeuroPace, Inc.NPCENASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +19.18% | +24.28% | +22.14% | +29.89% | +23.86% |
| Gross Profit Growth | +19.51% | +29.97% | +28.29% | +37.28% | +27.12% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +15.35% | +11.30% | +13.90% | +12.53% | +9.39% |
| Weighted Average Shares Diluted Growth | +15.35% | +11.30% | +13.90% | +12.53% | +9.39% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +4.36% | +32.71% | +20.57% | +29.21% | +14.24% |
| Inventory Growth | +19.32% | +18.96% | +43.85% | +50.07% | +26.27% |
| Asset Growth | -12.08% | +11.48% | +12.42% | +11.37% | +11.54% |
| Book Value per Share Growth | -66.37% | +52.05% | +72.65% | +67.52% | +117.12% |
| Debt Growth | +1.30% | +0.09% | -2.91% | -3.15% | -3.41% |
| R&D Expense Growth | +12.52% | +28.63% | +12.86% | +14.29% | +16.15% |
| SG&A Expenses Growth | +4.33% | -0.36% | +26.66% | +23.60% | +11.07% |